Medical Cannabis In the Care of the Elderly
|
|
- Rosalind Owens
- 5 years ago
- Views:
Transcription
1 Medical Cannabis In the Care of the Elderly April 19, 2018 Canadian Geriatrics Society Annual Scientific Meeting Michael A. Dworkind MDCM. CCFP. FCFP. Associate Professor Family Medicine and Palliative Care, McGill University
2 Disclosures Co-founder and medical director of Santé Cannabis, Santé Cannabis receives some funding in the form of grants from Canadian Licensed Producers of medical cannabis and is funded for the administration of clinical trials as a contract research organization by trial sponsor Tetra Bio-Pharma Inc.
3 Learning Objectives To better understand the complexity and controversial history of medical cannabis To learn about the Endocannabinoid System and its clinical relevance in the elderly To assess the [limited] evidence for potential efficacy and possible side effects when considering medical cannabis treatment Case study for review and discussion
4 Case Study: H.R. (90y F) Dx: Anorexia, attributed to major depression, mixed dementia, stroke, coronary artery disease, orthostatic hypotension, osteoarthritis, frailty Symptoms: low/no appetite, weight loss lb per week, extreme fatigue, spends most days lying in bed Rx: Desipramine 10mg, oolanzapine 5mg QHS PRN, Esomeprazole 40mg QD, Rosuvastin 20mg QD, Florinef
5 A brief history of cannabis in medicine. Cannabis has been used as a medicine by humans for several millennia. Between 1840 and , cannabis tinctures and other products became a mainstay of the pharmacopeia.
6 4000 BCE : Oldest evidence of cannabis and hemp production in China BCE: Papyrus Ebers (Egypt) first recorded mention of cannabis in obstetrics. 19th century: Queen Victoria uses cannabis tincture for menstrual cramps.
7 Cannabis was prohibited in Canada in 1923, and in the United States in 1937, citing quality control issues, lack of defined chemistry, but ultimately both political and ideological auspices. This period of cannabis as planta non grata has restricted access for researchers and clinicians, stifling its full potential as a medicine.
8 History continued : First isolation and synthesis of active components in cannabis THC and CBD. 1980s: Discovery of the endogenous cannabinoid system. First pharmaceutical version of THC available by prescription (Marinol). 2000: Canada legalizes medical cannabis Marihuana Medical Access Program Patients could grow their own medical supply under this program or buy from a single government supplier.
9 2016: Access to Cannabis for Medical Purposes Regulations (ACMPR) - Current program includes commercial sale to authorized patients and home production by patients or caregivers July?, 2018: Legalization expected via the Cannabis Act These developments, coupled with a resurgence of anecdotal accounts and renaissance of therapeutic clinical trials has cause a tsunami of interest.
10 Cannabis use in the senior population The fastest growing demographic of cannabis users (data from Colorado) Schauer et al., Am J Prev Med 2016
11
12 The pharmacology of medical cannabis The discovery of the endocannabinoid system (ECS) triggered an avalanche of experimental studies that have implicated the ECS in a growing number of physiological/pathological functions. Modulating the human endocannabinoid system in human health and disease: successes and failures. - Pal Pasher and George Kunos The FEBS Journal 2013 (Federation of European Biochemical Societies)
13 The Endogenous Cannabinoid System (ECS) The ECS is a system of neuromodulatory lipids (cannabinoids), their receptors, and their associated enzymes. CB1 receptors are found mainly in the brain and central nervous system. CB2 receptors are found mainly in peripheral organs and cells associated with the immune system. ECS is implicated in many physiological functions, notably: nociception, neuroprotection, homeostasis, inflammation, memory, sleep, mood, anxiety, appetite, among others.
14 Expression of GABA and Glutamate type receptors change as we age Hypothesized to affect brain s response to endocannabinoid phyto-cannabinoid activity
15 CB1 receptors implicated in essential function
16 Cannabinoids Cannabinoids interact with the CB1 and CB2 receptors to exert their effects; they can be endogenous, plant-based, or synthetic. More than 100 phytocannabinoids have been identified in cannabis plants. Anandamide (AEA), and 2-arachidonyl glycerol (2-AG) are endocannabinoids produced by the body. Delta-9 Tetrahydrocannabinol (THC) and Cannabidiol (CBD), are phytocannabinoids produced by the cannabis plant. Dronabinol,(THC) Nabilone (CB1 receptor agonist pharmaceutical, synthetic cannabinoids
17
18
19 105 publications of controlled trials included older subjects (>65 years) Only 5 reported results of older subjects separately! Found oral THC (3) and THC:CBD formulations No efficacy on levodopa induced dyskinesia, breathlessness or chemotherapy-induced nausea and vomiting THC might be useful in the anorexia and behavioural symptoms of dementia Most common adverse effect in the elderly using cannabinoids is sedation Considering the interest and increasing use rate in older persons, more study is required, especially sufficiently powered trials
20
21 Abuhasira et al Eur J Intern Med 2018
22 93.7% <Slight improvement> or better Abuhasira et al Eur J Intern Med 2018
23 Management of Chronic neuropathic Pain Moulin DE et. Al. Pain Research Management 2014, 19(6);
24 Safety of Cannabis for chronic pain 215 subjects and 216 controls, with chronic non-cancer pain Increased risk of non-serious adverse events in the cannabis group, however most were mild-moderate No difference in secondary safety assessment, pulmonary and neurocognitive function, hematology, biochemistry, renal, liver, endocrine function Ware MA et al. Journal of Pain December; 16(12):
25 Cancer pain Patients with advanced cancer and inadequate analgesia despite chronic opioid dosing were treated with THC extract or THC:CBD extract Both groups experienced significant pain reduction vs. placebo with twice as many patients in the THC:CBD group reporting pain reduction of 30%
26 Anorexia and cachexia syndrome Dronabinol: increased appetite and weight stability in HIV/AIDs and dementia Dronabinol versus megestrol acetate for cancer-associated anorexia: findings in favor of megestrol THC (2.5 mg) versus THC (2.5 mg) +CBD (1mg) versus placebo: no significant improvements in survival, weight, or other nutritional variables Improved taste, smell and food enjoyment Jatoi, A et al. J Clin Oncol 2002 Strasser F, et al. Journal of Clin Onco 2006; 24: Beal JE, et al. J Pain Symptom Management :89-97
27 Health Canada has aggregated relevant pre-clinical and clinical evidence for the medical use of cannabis and cannabinoids in this document.
28 Potential Indications Health Canada lists approximately 40 potential indications for dried cannabis. Strongest evidence base for: HIV/AIDS Multiple Sclerosis Epilepsy Spinal Cord Disease/Injury Cancer cachexia, anorexia Severe Arthritis Severe Chronic Pain Gastrointestinal disorders
29 THC (delta-9 tetrahydrocannabinol) Intoxicant Analgesic Anti-emetic Anti-spasmodic Anti-inflammatory Appetite Stimulant Anxiolytic (bi-phasic) Sleep Aid (bi-phasic) Apoptogenic, Anti-proliferative
30 CBD (cannabidiol) Non-intoxicant Anti-epileptic Anti-inflammatory Mild analgesic Anxiolytic Reduces spasticity Antipsychotic Apoptogenic, Anti-proliferative
31 Dosing strategy: Start low, Go slow, Stay low The efficacy of medical cannabis is directly related to strain and/or product selection and dosage. Patients typically undergo a trial period to determine which strains, methods administration and dosages are most effective.
32 Medical Cannabis (Phytocannabinoids) Cannabis is a plant medicine that comes in many forms: Dried cannabis flowers (aka: marijuana) Liquid oils, alcohol and glycerine tinctures Food products (aka: edibles, pot brownies) Topical oils, creams, and lotions Resins, extracts and concentrates (aka: hashish) Hundreds of cannabis strains with unique chemical profiles 100+ phytocannabinoids identified in cannabis strains from around the globe.
33 Pharmaceutical Cannabinoids Nabilone Synthetic THC analogue / CB1 Receptor Agonist 0.25mg, 0.5mg, 1mg formats RAMQ covers 0.5mg, 1.0mg Approved for chemotherapy induced nausea. Nabiximols Plant-derived oro-buccal spray approved for treating spasticity in Multiple Sclerosis. 2.7mg THC + 2.5mg CBD per spray Not covered by RAMQ, or most private insurance
34 Pharmaceutical Cannabinoids Prescribing Nabilone for geriatric patients Start with 0.25mg QHS for pain, sleep for 1 week Move to 0.5mg BID, increase to 1mg at night as needed RAMQ covers 0.5mg and multiples Effects can last up to 8 hours Cautious of sedation, dizziness, balance Small percentage find benefit for pain despite sleep improvements If not tolerated, or insufficient benefit...
35 Cannabis formulations in the legal framework Dried cannabis % w/w THC : CBD THC-rich THC:CBD CBD-rich Cannabis oil mg/ml (THC : CBD) Cannabis oil capsules mg (THC : CBD) per capsule
36 New Applications (topical, sprays, etc) to come
37 Clinical Model (Santé Cannabis) Specialized and patient-centred Research assistant Referral verification Screening Consent process Research Nurse Review of complete medical history. Verification of Inclusion/Excusion criteria Referring physician Referral & Supporting documentation Ongoing primary care Patient and family Report to MD Ongoing collaboration Physician Medical assessment Cannabinoid checklist Development plan Treatment Plan Cannabis Nurse-Educator Operationalization of Tx plan Education and support Follow-up 1-3 months Goal: Continuity of Care Monitoring Safety & Efficacy
38 Warnings and Precautions Sensitivity to THC Activities requiring co-ordination Driving, reduced mobility, vertigo, dizziness Possible interactions with other medications CNS Depressants, Opioids, Sedatives, blood thinners, SSRIs Substance abuse potential Geriatrics: restrict oral administration to BID watch for renal insufficiency Engage with your patient to reduce harms (illegal sources, unsupervised recreational use
39 Contraindications Uncontrolled cardiac disease Severe liver or renal dysfunction Severe respiratory disease (COPD) (inhalation) History of psychosis, schizophrenia (THC) Allergy or hypersensitivity to cannabinoids NB: Most contraindications relate only to THC, and not to more benign cannabinoids like CBD Need further research, including potential drug interactions Nothing clinically significant has been identified in the literature
40 Potential Adverse Effects of THC Possible Side-Effects Can often be avoided with careful titration and close followup Most Common Sedation Fatigue Somnolence Dry Mouth CBD cannabidiol Occasional Euphoria Postural, orthostatic hypotension Dizziness Vasodilation Headache Nausea, vomiting Tachycardia Rare Panic attack Dysphoria, paranoia Hallucinations Depression Cognitive impairment Ataxia Psychosis (under 25, predisposed)
41 Regulatory Framework
42 Access to Cannabis for Medical Purposes Regulations (ACMPR) Since 2016 in Canada, the production and sale of medical cannabis is overseen by Health Canada via the Access to Cannabis for Medical Purposes Regulations (ACMPR)
43 Licensed Producers (LPs) Only legal sources of medical cannabis Not available in the pharmacy Licensed Producers are strictly regulated by Health Canada Dried cannabis, Cannabis oils and capsules are available Many varieties of cannabis with specific concentrations of THC and CBD Cannabis is delivered via secure courier Storefront sales (ie: compassion clubs) are still illegal
44 Guidelines are provincially specific Dried cannabis is considered an «unrecognized treatment» Unrecognized treatments may only be prescribed under a research protocol (Quebec Cannabis Registry) Pharmaceutical options including pharmaceutical cannabinoids must be considered before prescribing dried cannabis Follow up with patients at least every 3 months Quebec Cannabis Registry currently recruited more than 2000 patients
45 Case Study: H.R. (90y F) Dx: Anorexia, attributed to major depression, mixed dementia, stroke, coronary artery disease, orthostatic hypotension, osteoarthritis, frailty Symptoms: low/no appetite, weight loss lb per week, extreme fatigue, spends most days lying in bed Rx: Desipramine, olazapine, esomeprazole, rosuvastin, florinef
46 Case Study: H.R. (90y F) Tx Objectives: Initial visit Improve appetite, stop weight loss (weight: 85 lbs) Tx: THC-rich Cannabis Oil 1mg BID, approximately 2 hours before meals CBD-rich Cannabis Oil 2mg QHS (for sleep, and bedtime anxiety) Outcomes: Almost immediate appetite improvement Increased daily activity, Improved mood Side effects: some additional cognitive effects from baseline, ie. short-term memory loss
47 Case Study: H.R. (90y F) Follow-up (1 month) Tx: THC-rich Oil 1mg only QAM ~2 hrs before lunch CBD-rich Oil 2mg QHS Desipramine, olazapine, esomeprazole, rosuvastin discontinued, florinef reduced Outcomes: Increase appetite maintained at 1mg THC daily Weight increasing 0.5lb per week Increased daily activity, reduced joint pain Improved mood Reducing to 1mg THC daily resolved the worsening cognitive concerns (back to baseline)
48 Case Study: H.R. (90y F) Follow-up (1 year) Tx: THC-rich Cannabis Oil 3mg QAM and 1mg QPM CBD-rich Oil 2mg QHS Outcomes: Weight increased back to 107 lbs Still experiences fatigue, daily THC augments energy and mood No change in cognition with increased THC (some tolerance) Reduced joint pain and inflammation Reduced caregiver burnout over spoon-feeding stress
49 Future Directions: Canada as a global leader in medical cannabis research?
50 SAFETY AND EFFICACY OF PPP001-kit FOR IMPROVING HEALTH RELATED QUALITY OF LIFE IN ADVANCED CANCER PATIENTS WITH UNCONTROLLED PAIN: A RANDOMIZED, DOUBLE-BLIND, PLACEBO- CONTROLLED, PARALLEL GROUP STUDY Principal Investigator: Antonio Vigano, MD, MSc Site: Santé Cannabis Phase III clinical trial Study duration: 6 weeks in duration including the following: A screening period of up to 2 weeks A 4-week treatment period Primary objective: To evaluate the effect of a specific formulation of dried cannabis to improve HRQoL of patients with uncontrolled cancer pain and incurable malignancy
51 Questions?
52 Some resources Santé Cannabis Canadian Consortium for the Investigation of Cannabinoids International Cannabinoid Research Society Information for Healthcare Professionals Medical Cannabis (Health Canada)
Use of Cannabinoids in Medical Practice
Use of Cannabinoids in Medical Practice Annual Scientific Assembly Family Medicine Review 2016 Murray Opdahl BSPE, MD, CCFP Objectives Briefly present: An overview of available cannabinoids Concerns voiced
More informationMedical Cannabis. Danial Schecter, MD, CCFP. Vocational Rehabilitation Association November 7th, Executive Director Cannabinoid Medical Clinic
Medical Cannabis Danial Schecter, MD, CCFP Executive Director Cannabinoid Medical Clinic Vocational Rehabilitation Association November 7th, 2014 Conflict of Interest This program has not received financial
More informationCANNABIS FOR THE RHEUMATOLOGIST
CANNABIS FOR THE RHEUMATOLOGIST Dr Jagtar Singh Nijjar NIHR Clinical Lecturer in Rheumatology Disclosures None 1 Overview The history of cannabis use Anecdotal use of cannabis in chronic pain The biology
More informationMedical Marijuana Martin P. Eason MD, JD Associate Chief of Staff for Education Mountain Home VA Medical Center. Disclosure.
Medical Marijuana Martin P. Eason MD, JD Associate Chief of Staff for Education Mountain Home VA Medical Center Controversies in Pain Management Conference Johnson City, TN November 13, 2015 Disclosure
More informationResearch on Cannabis and PD: Is there any evidence?
Research on Cannabis and PD: Is there any evidence? Benzi M. Kluger, MD, MS Associate Professor of Neurology and Psychiatry Director Movement Disorders Center University of Colorado Denver DISCLOSURES
More informationMedical Cannabis use in the Older Patient. Amanjot Sidhu, MD, FRCPC Division of Geriatric Medicine McMaster University
Medical Cannabis use in the Older Patient Amanjot Sidhu, MD, FRCPC Division of Geriatric Medicine McMaster University Disclosure Relationships with commercial interests: Grants/Research Support: none Speakers
More informationCannabinoids: access and symptom management in cancer
Cannabinoids: access and symptom management in cancer Appetite stimulation Anecdotal reports suggest marijuana stimulates appetite AIDS/HIV dronabinol 2.5 mg bd v placebo (n=88) increase in appetite 38%
More informationCANNABIDIOL IN THE TREATMENT OF CHRONIC NEUROPATHIC PAIN IN CANCER PATIENTS
CANNABIDIOL IN THE TREATMENT OF CHRONIC NEUROPATHIC PAIN IN CANCER PATIENTS Antonio Vigano, MD, MSc Attending Physician, Supportive and Palliative Care Division, McGill University Health Centre (MUHC)
More informationMedical Cannabis use in the Older Patient
Medical Cannabis use in the Older Patient Dr. Amanjot Sidhu Division of Geriatric Medicine McMaster University Audience Poll What is the fastest-growing demographic of cannabis users? a) Ages 14-23 b)
More informationAcknowledgements: What it is What it s not. Cannabis Evidence Series. Evidence-informed decision-making
Cannabis Evidence Series What it is What it s not Acknowledgements: The evidence presented is from the Cannabis evidence series authored by the HTA unit at the University of Calgary and from Rapid response
More informationMedical Cannabinoids for the Management of Chronic Noncancer Pain
Medical Cannabinoids for the Management of Chronic Noncancer Pain Dr Mark A. Ware MBBS MSc McGill University 12 June 2018 Disclosures Grants: CanniMed Consulting: CHI Inc Emmes 1 Canadian Consortium for
More informationMedical Marijuana Update Chris Belletieri, DO
Dr. Belletieri has provided no disclosures. Graduated PCOM in 1996 In private practice since 1999 Board Certified in FP since 1999 Program Director of FP residency at Lower Bucks Hospital in Bristol, PA
More informationPOLICY NUMBER: POL 153
Chapter: CLAIMS Subject: MEDICAL CANNABIS Effective Date: October 25, 2018 Last Update: October 25, 2018 PURPOSE STATEMENT The purpose of this policy is to explain how the Workers Compensation Board determines
More informationMedical Cannabis MATT WEBSTER DO, MS
Medical Cannabis MATT WEBSTER DO, MS Cannabis Sativa One of the oldest used drugs and medicinal remedies Most commonly abused illicit drug in the US There has been increasing access for medicinal MJ use
More informationThe Effects known & unknown of Marijuana in Older Adults. Danielle Fixen, PharmD, BCGP, BCPS University of Colorado School of Pharmacy
The Effects known & unknown of Marijuana in Older Adults Danielle Fixen, PharmD, BCGP, BCPS University of Colorado School of Pharmacy Learning Objectives 1. Review various dosing strategies for medical
More informationObjectives. 1. Review controversy 2. Pathophysiology 3. Indications for Use 4. Adverse Effects 5. How Patients Access
Medical Marijuana Deb Evans, RN, MScN, CON(C), CHPCN(C) Clinical Nurse Specialist Pain and Symptom Management Team Juravinski Cancer Centre May 29, 2014 Objectives 1. Review controversy 2. Pathophysiology
More informationFederal Law: Marijuana
Federal Law: Marijuana Marijuana is a Schedule I drug under Federal Controlled Substances Act Makes possession, usage, purchase, sale, and/or cultivation of marijuana illegal at the federal level May not
More informationJames McCormack BSc (Pharm), PharmD Professor Faculty of Pharmaceutical Sciences University of British Columbia Vancouver, BC, Canada
James McCormack BSc (Pharm), PharmD Professor Faculty of Pharmaceutical Sciences University of British Columbia Vancouver, BC, Canada My Agenda Discuss the best available evidence Put the evidence into
More informationHistory Of Medical Cannabis
History Of Medical Cannabis Historical and archaeological evidence of widespread use in ancient times as medicine, food, textiles & for sacraments, rituals Possibly first domesticated crop Introduction
More informationMedicinal Marijuana: The Canadian Journey
Medicinal Marijuana: The Canadian Journey Nady el-guebaly MD Professor & Head, Addiction Division, UofC Research Director, Alberta Gambling Research Institute Chief Examiner, ISAM Certification Disclosures:
More informationThe Return of Medicinal Cannabis
The Return of Medicinal Cannabis George Kolodner, M.D. DLFAPA FASAM Chief Clinical Officer Clinical Professor of Psychiatry Georgetown University School of Medicine University of Maryland School of Medicine
More informationDr. G. Michael (Michael) Allan EDMONTON AB Dr. Christina (Tina) S. Korownyk EDMONTON AB MEDICAL CANNABANOIDS IN PRIMARY CARE
Society of Rural Physicians of Canada 26TH ANNUAL RURAL AND REMOTE MEDICINE COURSE ST. JOHN'S NEWFOUNDLAND AND LABRADOR APRIL 12-14, 2018 262 Dr. G. Michael (Michael) Allan EDMONTON AB Dr. Christina (Tina)
More informationMedicinal cannabinoids where does it fit in Palliative Care? Janet Hardy Phillip Good Georgie Cupples Matthew Spitzer
Medicinal cannabinoids where does it fit in Palliative Care? Janet Hardy Phillip Good Georgie Cupples Matthew Spitzer Medicinal cannabis Substantial public interest Legalised by the Qld Government Guidance
More informationConsumer Information Cannabis (Marihuana, marijuana)
Consumer Information Cannabis (Marihuana, marijuana) The courts in Canada have ruled that the federal government must provide reasonable access to a legal source of marijuana for medical purposes. The
More informationThe Cannabis model in Canada and the USA. Dr Mark A Ware MD MRCP MSc McGill University Montreal, Quebec, Canada
The Cannabis model in Canada and the USA Dr Mark A Ware MD MRCP MSc McGill University Montreal, Quebec, Canada Outline Canada Cannabinoid medicines Existing regulatory framework Proposed new regulations
More informationMedical Marihuana for Patients in the Lymphoma Setting. Speakers: Ruth Turner, RN, Con Rob Laister, PhD
Medical Marihuana for Patients in the Lymphoma Setting Speakers: Ruth Turner, RN, Con Rob Laister, PhD Medical Marihuana for Patients in the Lymhoma Setting Disclosure: No endorsement or promotion of marihuana
More informationMedicinal Cannabis. Patient Log Book. Record your cannabis use and find the right dose
Medicinal Cannabis Patient Log Book Record your cannabis use and find the right dose 1 Introduction A federal system is in place for medicinal cannabis that is distinct from recreational sales. To get
More informationMedical Marijuana Consent Form
Medical Marijuana Consent Form A qualified physician may not delegate the responsibility of obtaining written informed consent to another person. The qualified patient or the patient s parent or legal
More informationAct 16 and Medical Cannabis in Pennsylvania
Act 16 and Medical Cannabis in Pennsylvania Charles V. Pollack, Jr., MA, MD, FACEP, FAAEM, FAHA, FESC, FCPP Associate Provost and Professor of Emergency Medicine Director, Institute of Emerging Health
More informationMedicinal cannabis. What is medicinal cannabis? What are cannabinoids? The endocannabinoid system
Medicinal cannabis What is medicinal cannabis? Broadly speaking, medicinal cannabis is cannabis prescribed to relieve the symptoms of a medical condition, such as epilepsy. It is important to make the
More informationMEDICAL CANNABIS IN MINNESOTA
MEDICAL CANNABIS IN MINNESOTA MINNESOTA ACADEMY OF PHYSICIAN ASSISTANTS MARCH 18, 2016 TOM ARNESON, MD, MPH MDH OFFICE OF MEDICAL CANNABIS 2014: Minnesota becomes 22 nd state with a medical cannabis program
More informationADVANCED CLINICAL CANNABINOID PROVIDER EXAM ACCP
ADVANCED CLINICAL CANNABINOID PROVIDER EXAM ACCP Page 1 1. In what year did the possession and transfer of cannabis for recreational use become illegal in the United States? A. 1937 B. 1941 C. 1933 2.
More informationJames Donaldson CEO and Executive Director
Welcome! James Donaldson CEO and Executive Director Dr. Natasha Ryz Chief Science Officer, Zenabis Cannabis 101 Introduction to Cannabis Plant Cannabis is a genus of flowering plants within the family
More informationMEDICAL MARIJUANA: WHAT S THE EVIDENCE?
MEDICAL MARIJUANA: WHAT S THE EVIDENCE? L A U R A A. M A R K L E Y, M D B O A R D - C E R T I F I E D I N P E D I A T R I C S / G E N E R A L P S Y C H I A T R Y / C H I L D & A D O L E S C E N T P S Y
More informationThe Shifting Federal Regulation of Cannabis Products
The Durham Bar 2019 CLE Program The Shifting Federal Regulation of Cannabis Products Erica M. Jackson, FDA Partner K&L Gates February 6, 2019 Copyright 2018 by K&L Gates LLP. All rights reserved. OVERVIEW
More informationCANNABIS LEGALIZATION: SUPPORT MATERIAL FOR MANITOBA PHYSICIANS
CANNABIS LEGALIZATION: SUPPORT MATERIAL FOR MANITOBA PHYSICIANS 1. GENERAL INFORMATION Cannabis 101 What is cannabis? Cannabis is a product derived from the Cannabis sativa plant. Cannabis contains hundreds
More informationCannabis and What we Know. Bonnie Schnittker RN PHN Public Health Nurse October 20, 2017
Cannabis and What we Know Bonnie Schnittker RN PHN Public Health Nurse October 20, 2017 We All Have a Role to Play! Objectives What is Cannabis? What do we know about the health effects? Legalization:
More informationRecent trends in medical cannabis use in Canada
Recent trends in medical cannabis use in Canada Paul Grootendorst Faculty of Pharmacy, University of Toronto Department of Economics, McMaster University Cannabis therapeutic effects Cannabis has been
More informationCurious about Cannabis? Navigating the cannabis landscape in Pennsylvania LINDSEY MESTON, PHARMD ASHLEY FIRM, PHARMD
Curious about Cannabis? Navigating the cannabis landscape in Pennsylvania LINDSEY MESTON, PHARMD ASHLEY FIRM, PHARMD Speaker Disclosures We have/had no financial relationships with any commercial interests
More informationThis is a duplicated text of a letter from GW Pharma Ltd. Contact the company for a copy of any references, attachments or enclosures.
Health Canada posts safety alerts, public health advisories, press releases and other notices from industry as a service to health professionals, consumers and other interested parties. Although Health
More informationJuly 15 TH, ANDREW MEDVEDOVSKY, M.D. Board Certified Neurologist & Pain Medicine Specialist Director New Jersey Alternative Medicine
MEDICAL CANNABIS FOR NEUROLOGICAL DISEASES July 15 TH, 2017 ANDREW MEDVEDOVSKY, M.D. Board Certified Neurologist & Pain Medicine Specialist Director New Jersey Alternative Medicine GOALS AND OBJECTIVES
More informationCannabidiol, or CBD, Benefits for Pain, Mental Illness & Anxiety
Cannabidiol, or CBD, Benefits for Pain, Mental Illness & Anxiety The use of medical marijuana continues to be an emotionally and politically charged issue. Although cannabis oil preparations have been
More informationCANNABIS AND PAIN. Debra Kimless, M.D. Medical Director, ForwardGro MAOP Annual Meeting September 14, 2018
CANNABIS AND PAIN Debra Kimless, M.D. Medical Director, ForwardGro MAOP Annual Meeting September 14, 2018 FDA APPROVAL: PREGABALIN, DULOXETINE, MILNACIPRAN FOR FIBROMYALGIA PREGABALIN, DULOXETINE FOR
More informationMedicinal Marijuana: Closing the gap between anecdotal benefits and evidence-based research. Jonathan Kiesman, Pharmacist CanniMed Ltd.
Medicinal Marijuana: Closing the gap between anecdotal benefits and evidence-based research Jonathan Kiesman, Pharmacist CanniMed Ltd. Presenter Disclosure Presenter: Jonathan Kiesman Relationship with
More informationCDHA 2016 Fall Symposium. Speaker Handout Files. For registered attendees only
CDHA 2016 Fall Symposium Speaker Handout Files For registered attendees only Providing Care in a Marijuana Legal World Heather Rogers, BSDH heatherrdh@heatherrdh.com Objectives We will discuss some of
More informationThis questionnaire will ask you about approved medical use of extracts and tinctures of cannabis at national level.
Introduction This questionnaire will ask you about approved medical use of extracts and tinctures of cannabis at national level. Definition: The term "extracts and tinctures" refers to substances that
More informationCANNABINOIDS AND APPETITE: A PROMISING RELATIONSHIP?
CANNABINOIDS AND APPETITE: A PROMISING RELATIONSHIP? MariaLuisa Vigano, Maria-Fernanda Arboleda, Erin Prosk, Youri Drozd, Michael Dworkind, Popi Kasvis MASCC/ISOO Annual Meeting on Supportive Care in Cancer
More informationMedical Marijuana. 1. is a plant species, variety known as hemp. 3. Tetrahydrocannabinol is an aromatic with low water solubility.
Medical Marijuana Questions from Part 1: 1. is a plant species, variety known as hemp. a. Cannabis sativa Linnaeus b. Cannabis sativa c. Cannabis indica d. Cannabis Lemark 2. The major psychoactive compound
More informationMEDICAL CANNABIS IN MINNESOTA
MEDICAL CANNABIS IN MINNESOTA EPILEPSY & SEIZURES WELLNESS EXPO APRIL 16, 2016 MICHELLE LARSON, MPA MDH OFFICE OF MEDICAL CANNABIS 2014: Minnesota becomes 22 nd state with a medical cannabis program State
More informationFaculty/Presenter Disclosure
Faculty/Presenter Disclosure Faculty: Philippe Lucas Relationships with commercial interests: Philippe Lucas is a Research Affilliate with the Centre for Addictions Research of BC, as well as VP, Patient
More informationA look at Marijuana in 2014
A look at Marijuana in 2014 Paul Snyder MA., LADC Overview and Objectives Discuss the mental and physical effects of marijuana use Describe the criteria for Cannabis use disorder according to the DSM 5
More informationMedical Marijuana. Speaker Disclosure Requirements. Share with a Partner 4/10/2015
Medical Marijuana Kent W. Peterson, MD, FACOEM Occupational Health Strategies, Inc. Charlottesville, VA Speaker Disclosure Requirements 1. Do not dispense, prescribe, refer or recommend MMJ 2. Have no
More informationLife s brighter under the sun MEDICAL CANNABIS AND GROUP BENEFITS PLAN COVERAGE
Life s brighter under the sun MEDICAL CANNABIS AND GROUP BENEFITS PLAN COVERAGE With the legalization of recreational cannabis upon us in Canada, our conversation about cannabis use is changing. It s not
More informationDr. Meldon Kahan. Women s College Hospital. with PIA LAW
with PIA LAW and Toronto ABI Network Dr. Meldon Kahan Women s College Hospital Dr. Meldon Kahan is an Associate Professor in the Department of Family Medicine at University of Toronto, and Medical Director
More informationCannabis and the Endocannabinoid System
Cannabis and the Endocannabinoid System September 7, 2018 Bangkok, Thailand David Bearman, MD Goleta, California Executive VP, American Academy of Cannabinoid Medicine AACMSITE.org Shen Nung Ping
More informationMedical vs Recreational Use of Cannabis. 11 th December 2017
1 Medical vs Recreational Use of Cannabis 11 th December 2017 2 Defining Cannabis and Chemical Constituents Cannabis is a plant species. Two main Cannabis sub-species are Cannabis Sativa and Cannabis Indica.
More informationMarijuana and Adolescents: Truth and Consequences. Disclosure Statement OBJECTIVES. Secondary Objectives. State of Marijuana in US
Marijuana and Adolescents: Truth and Consequences Clinical Advances in Pediatrics Symposium Children s Mercy Park September 28, 2017 Disclosure Statement I have no actual or potential conflict of interest
More informationCannabidiol as a potential treatment for anxiety disorders. Esther Blessing, MD PhD
Cannabidiol as a potential treatment for anxiety disorders Esther Blessing, MD PhD Overview History and of cannabidiol (CBD) and cannabis Safety and tolerability of CBD CBD pharmacology Clinical need for
More informationResearch: Medical Cannabis
Research: Medical Cannabis Background The hemp plant Cannabis sativa (cannabis) is commonly known as marijuana and can be used as a therapy to alleviate symptoms such as pain and fatigue caused by chronic
More informationCBD Oil: Benefits, Top Products, Where To Buy, And More
CBD Oil: Benefits, Top Products, Where To Buy, And More CBD hemp oil has a huge range of potential health benefits and uses, including reducing pain, soothing anxiety, fighting cancer, improving mood,
More informationMedical Marijuana A Primer for Pharmacists
Medical Marijuana A Primer for Pharmacists Emory S. Martin, PharmD FASHP Texas Society of Health System Pharmacists Learning Objectives Recognize key components of the endocannabinoid system Identify possible
More informationMedical Marijuana: The Move to Schedule II
Medical Marijuana: The Move to Schedule II David Deitz, MD, PhD David Deitz & Associates Today s discussion Does medical marijuana actually treat anything? What are the workplace issues? What are the interactions
More informationMEDICAL CANNABIS QUICK REFERENCE GUIDE
MEDICAL CANNABIS QUICK REFERENCE GUIDE CANNABIS 101: MEDICINE HOW IT WORKS DEFINITIONS Cannabinoids Class of compounds that act on cannabinoid receptors in the human body (Internal or External) Endocannabinoids
More informationMedical Marijuana. Navigating Medical Marijuana in Workers Compensation
Medical Marijuana Navigating Medical Marijuana in Workers Compensation Agenda Federal and State Laws Public Health Adverse Effects & Concerns Clinical Use Implications for Employers Implications for Workers
More informationLearning Objectives 1/8/2019. Therapeutic Potential of the Marijuana-Derived Cannabinoids THC and CBD. Disclosures. Outline. Take home messages
Therapeutic Potential of the Marijuana-Derived Cannabinoids THC and CBD CECILIA HILLARD, PHD DEPARTMENT OF PHARMACOLOGY NEUROSCIENCE RESEARCH CENTER Disclosures Member of the Scientific Advisory Board
More informationUSING ALTERNATIVE MEDICATION: MEDICAL CANNABIS (MARIJUANA)--BENEFITS AND HARMFUL EFFECTS JENNIFER KAPUR, PHARM.D. MARCH 1, 2016
USING ALTERNATIVE MEDICATION: MEDICAL CANNABIS (MARIJUANA)--BENEFITS AND HARMFUL EFFECTS JENNIFER KAPUR, PHARM.D. MARCH 1, 2016 OBJECTIVES Compare and contrast federal law and state laws regarding marijuana
More information420 ADVISORY MANAGEMENT
THE CANNABIS ACT: WHAT DOES IT MEAN FOR CANADIANS? 420 CLINIC, LTD. OBJECTIVES At the end of the session, you will be able to: 1) Understand the ramifications of recreational cannabis legalization 2) Understand
More informationQuestionnaire 1 of 5: Cannabis Plant and Cannabis Resin. Introduction
Introduction This is one of five questionnaires that Member States are invited to complete ahead of the 40th WHO Expert Committee on Drug Dependence. This questionnaire will ask you about cannabis plant
More informationmedical cannabis solutions HEALTHCARE PROFESSIONALS GUIDE
medical cannabis solutions HEALTHCARE PROFESSIONALS GUIDE support@naturalcaregroup.com 1.888.671.8022 N A T U R A L C A R E G R O U P. C O M inside What s Working with Natural Care 2 How Natural Care works
More informationMedical Marijuana: Hype versus Evidence
Medical Marijuana: Hype versus Evidence Monica Malec, MD The University of Chicago, Department of Medicine Section of Geriatrics and Palliative Medicine Objectives Understand the requirements for physician
More informationWHO Expert Committee on Drug Dependence Pre-Review: Extracts and tinctures of cannabis. Expert Peer Review 2
WHO Expert Committee on Drug Dependence Pre-Review: Extracts and tinctures of cannabis Expert Peer Review 2 1. Comments based on the review report a. Evidence on dependence and abuse potential Extracts
More informationI would like to begin by acknowledging that we are on the ancestral grounds of the Beothuk people
I would like to begin by acknowledging that we are on the ancestral grounds of the Beothuk people Introduction to the Cannabinoid System And Medical Use Dr Alia Norman Radiation Oncologist Cannabinoid
More informationInvestigational Pharmacy Cannabidiol treatment in Epilepsy
Jon Beck BS Pharm D Coordinator Investigational Pharmacy Disclosure I have no relevant financial relationships with a Commercial Provider Nebraska Medicine Omaha, NE Investigational Pharmacy Cannabidiol
More informationCBD and Your Health.
CBD and Your Health. Cannabidiol (CBD) is a molecule found in plant species such as agricultural (or industrial) hemp, and Echinacea. CBD is one of at least 489 distinct compounds within hemp: it is clear
More informationCannabis. Member of the Cannabaceae family of flowering plants (along with hops) Cannabis sativa (v. sativa, indica, afghanica, ruderalis)
Member of the Cannabaceae family of flowering plants (along with hops) sativa (v. sativa, indica, afghanica, ruderalis) Only females flowers contain high concentrations of psychoactive oils (cannabinoids)
More informationMEDICAL CANNABIS QUICK REFERENCE GUIDE
MEDICAL CANNABIS QUICK REFERENCE GUIDE CANNABIS 101: MEDICINE MEDICAL CANNABIS QUICK REFERENCE GUIDE HOW IT WORKS DEFINITIONS Cannabinoids Class of compounds that act on cannabinoid receptors in the human
More informationMarijuana. DATE: February 21, 2017 PRESENTED BY: Melissa Weimer, DO, Assistant Professor of Medicine
Marijuana DATE: February 21, 2017 PRESENTED BY: Melissa Weimer, DO, Assistant Professor of Medicine Objectives Describe marijuana laws in the state of Oregon and the nation List evidence available for
More information9/13/2017. Marijuana and the Brain Matthew Wong, MD Assistant Professor, Department of Neurology, Epilepsy Section. Disclosures.
Marijuana and the Brain Matthew Wong, MD Assistant Professor, Department of Neurology, Epilepsy Section Disclosures Site principal investigator of studies of cannabidiol(epidiolex) in the treatment of
More informationMedical Marijuana for Pain How Does Cannabis Work on Your Body?
Medical Marijuana for Pain How Does Cannabis Work on Your Body? Jeremy Spiegel, MD Medical Director - Casco Bay Medical Westbury, Long Island, New York Intro Brief History of Cannabis Physiology of Cannabis
More informationBudding Therapies: Medical Cannabis and its Uses
Budding Therapies: Medical Cannabis and its Uses MARIAH CADAVOS, PHARMD & VIVIAN NGUYEN, PHARMD PGY1 PHARMACY PRACTICE RESIDENTS FEBRUARY 10, 2019 1 Disclosures & Disclaimer Both presenters have nothing
More informationMarijuana. DATE: June 26, 2018 PRESENTED BY: Melissa Weimer, DO, MCR, FASAM
Marijuana DATE: June 26, 2018 PRESENTED BY: Melissa Weimer, DO, MCR, FASAM Disclosures Speaker: Melissa Weimer, DO, MCR, has nothing to disclose. Planning Committee: The members of the planning committee
More informationGuidance for the use of. medicinal cannabis. in Australia. Patient information
Guidance for the use of medicinal cannabis in Australia Patient information Version 1, December 2017 Copyright Commonwealth of Australia 2017 This work is copyright. You may reproduce the whole or part
More informationLGP CLASSIC Oil Products
LGP CLASSIC Oil Products Patient Information Leaflet (PIL) PRODUCT RANGE Medicinal Cannabis Oil Extract LGP CLASSIC 10:10 LGP CLASSIC 10:15 LGP CLASSIC 20:5 What is in this leaflet Please read this leaflet
More informationThe Sale of Cannabis in Pharmacies. Michael H. Ghobrial, PharmD, JD Associate Director, Health Policy American Pharmacists Association
The Sale of Cannabis in Pharmacies Michael H. Ghobrial, PharmD, JD Associate Director, Health Policy American Pharmacists Association Development This activity was developed by the American Pharmacists
More informationIf Not Opioids then LEAH EDMONDS CSHP OCTOBER 26, 2017
If Not Opioids then what LEAH EDMONDS CSHP OCTOBER 26, 2017 Disclosure Nothing to disclose Objectives Identify various non-opioid options for the treatment of chronic non cancer pain Choose appropriate
More informationCannabis: Therapeutic properties of the plant
Cannabis: Therapeutic properties of the plant Medicinal cannabis is still illegal to be used in South Africa. In a victory for marijuana users across South Africa, ConCourt has officially legalised cannabis
More information9/28/2015. Support. R01CA A1 Intervening with smoking parents of inpatients to reduce
Medical marijuana and the impact of marijuana policy on children Karen M. Wilson, MD, MPH, FAAP Associate Professor of Pediatrics Section Head, Pediatric Hospital Medicine University of Colorado School
More informationUse of Medical Marijuana in Cancer Treatment & Care
Use of Medical Marijuana in Cancer Treatment & Care Ronald Stram,MD Stram Center for Integrative Medicine April 2016 Introduction Board Certified Medical Doctor, Integrative and Functional Medicine 28
More informationClinical Education Initiative MEDICAL MARIJUANA 101. Speaker: Patricia Reed, PharmD
Clinical Education Initiative Support@ceitraining.org MEDICAL MARIJUANA 101 Speaker: Patricia Reed, PharmD 8/2/2017 Medical Marijuana 101 [video transcript] 00:00:12 - So we'll get started. Disclosures
More informationOutcome. Educating Ohio Providers On The Basics Related To Recommending Medical Marijuana. Connie J. Cerilli, APRN, FNP-C
Educating Ohio Providers On The Basics Related To Recommending Medical Marijuana Connie J. Cerilli, APRN, FNP-C Outcome Participants will be able to list 3 approved medical conditions Participants will
More informationEducating Ohio Providers On The Basics Related To Recommending Medical Marijuana. Connie J. Cerilli, APRN, FNP-C
Educating Ohio Providers On The Basics Related To Recommending Medical Marijuana Connie J. Cerilli, APRN, FNP-C Outcome Participants will be able to list 3 approved medical conditions Participants will
More informationTHE COMPLETE CBD GUIDE
THE COMPLETE CBD GUIDE WHAT IS CBD (CANNABIDIOL)? 2 WHERE DOES CBD COME FROM? 3 HOW DOES CBD WORK IN THE BODY? 4 HOW MUCH CBD DO I TAKE? 5-6 CBD OIL VS. HEMP OIL 7 CBD NOT THC 8 THE BENEFITS OF CBD 9 PETS
More informationHEALTH WELLNESS COMMUNITY
HEALTH WELLNESS COMMUNITY As with all modern medicines, our understanding of cannabis and its benefits has deepened over time thanks to groundbreaking advancements in research and technology. At Trilogy
More informationDoc, will you sign my medical. Fellow in Hematology/Medical Oncology General Internal Medicine Grand Rounds
Doc, will you sign my medical marijuana card? Daniel W. Bowles, MD Fellow in Hematology/Medical Oncology General Internal Medicine i Grand Rounds September 21, 2010 Disclosures Skeptical about marijuana
More informationReefer Madness version 3.0*
Reefer Madness version 3.0* Presenter Disclosure *Original Reefer Madness: FMF 2014 by R. Dubin, Sharon Cirone and Mel Kahan Update on Health Canada s MMPR and the use of cannabis for medical conditions
More informationMedical Cannabis in Cancer Is the Smoke Clearing?
Medical Cannabis in Cancer Is the Smoke Clearing? Paul Daeninck, MD MSc FRCPC Departments of Internal & Family Medicine University of Manitoba and CancerCare Manitoba Conflict of interest disclosure Faculty:
More informationExplanatory note for Operational Policy Manual (OPM) # , Cannabis for Medical Purposes
Medical Cannabis Explanatory note for Operational Policy Manual (OPM) #17-01-10, Cannabis for Medical Purposes WSIB Explanatory note for OPM #17-01-10, Cannabis for Medical Purposes January 2019 1 Table
More informationMEDICAL CANNABIS PATIENT COUNSELING. Krissy Bernazani, RPh Clinical Director Zen Leaf
MEDICAL CANNABIS PATIENT COUNSELING Krissy Bernazani, RPh Clinical Director Zen Leaf DISCLOSURE Krissy Bernazani is a paid employee of Freestate Wellness, dba Zen Leaf Maryland, a medical cannabis dispensary.
More informationCannabis and Cannabinoids: Review of Existing and Potential Therapeutic Applications in Oncology
Cannabis and Cannabinoids: Review of Existing and Potential Therapeutic Applications in Oncology 2 Pamela C. Cartright, MAE, RT (R)(T) Assistant Professor and Program Director Radiation Therapy Program
More informationMedical Cannabis & Seniors - 101
Medical Cannabis & Seniors - 101 Presented by: Shannon O Hearn MSc., Clinical Research Project Manager Date: April 13 th, 2017 Agenda Who is MedReleaf? How Cannabis is currently regulated in Canada The
More information